Variable | Total group n = 176 | Cefuroxime n = 85 (48.3%) | Ampicillin/Sulbactam n = 91 (51.7%) | P - value |
---|---|---|---|---|
Age, median (IQR) | 28 (24-32) | 27 (23.5-31) | 28 (24-32) | 0.7 |
Multiparity, n (%) | 98 (55.7) | 48 (56.5) | 50 (54.9) | 0.9 |
BMI ≤24 kg/m2, n (%) | 39 (22.2) | 18 (21.2) | 21 (23.1) | 0.9 |
BMI ≥ 30 kg/m2, n (%) | 76 (43.2) | 38 (44.7) | 38 (41.8) | 0.8 |
Diabetes mellitus, n (%) | 7 (4) | 3 (3.5) | 4 (4.4) | 1 |
Hypertension (including pre-eclampsia)/other cardiovascular condition, n (%) | 36 (20.5) | 16 (18.8) | 20 (22) | 0.7 |
Chronic respiratory disease, n (%) | 1 (0.6) | 1 (1.2) | 0 (0) | 0.5 |
Corticosteroid use, n (%) | 2 (1.1) | 2 (2.4) | 0 (0) | 0.2 |
Creatinine in mg/dL, median (IQR) | 0.6 (0.5-0.7) | 0.6 (0.5-0.7) | 0.6 (0.5-0.7) | 0.6 |
ASA ≥ 2, n (%) | 59 (33.5) | 27 (31.8) | 32 (35.2) | 0.7 |
Regular prenatal f/u, n (%) | 167 (94.9) | 83 (97.6) | 84 (94.4) | 0.4 |
Vaginal examinations, n (%) | 96 (54.5) | 45 (52.9) | 51 (56) | 0.8 |
Vaginal examinations ≥ 6, n (%) | 23 (13.1) | 11 (12.9) | 12 (13.2) | 1 |
Ruptured membranes, n (%) | 54 (30.7) | 24 (28.2) | 30 (33) | 0.5 |
Ruptured membranes ≥ 6 hours, n (%) | 9 (5.1) | 3 (3.5) | 6 (6.6) | 0.5 |
Non-elective emergency cesarean, n (%) | 87 (49.4) | 42 (49.4) | 45 (49.5) | 1 |
General anesthesia | 110 (62.5) | 50 (58.8) | 60 (65.9) | 0.4 |
Duration of surgery >60 minutes, n (%) | 111 (63.1) | 53 (62.4) | 58 (63.7) | 0.9 |
Blood loss >500 ml, n (%) | 74 (42) | 37 (43.5) | 37 (40.7) | 0.8 |
All post-op infections, n (%) | 13 (7.4) | 5 (5.9) | 8 (8.8) | 0.6 |
Post-cesarean endometritis, n (%) | 4 (2.3) | 2 (2.4) | 2 (2.2) | 1 |
Post-cesarean SSI (includes endometritis), n (%) | 10 (5.7) | 4 (4.7) | 6 (6.6) | 0.7 |
Duration of hospitalization in days, median (IQR) | 4 (4-4) | 4 (4-5) | 4 (4-4) | 0.09 |
Duration of hospitalization post-operatively in days, median (IQR) | 2 (2-2) | 2 (2-2) | 2 (2-2) | 0.04 |